Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × romiplostim × Sarcoma × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1

Interventions

Magnetic Resonance Spectroscopy 5 Specimen Handling 3 Radiotherapy 3 Nivolumab 3 pembrolizumab 2 X-Rays 2 Oncolytic Virotherapy 2 Irinotecan 2 Doxorubicin 2 Cyclophosphamide 2 Biopsy 2 Bevacizumab 2 trastuzumab biosimilar HLX02 1 sodium thiosulfate 1 romiplostim 1 pertuzumab 1 perflutren 1 palbociclib 1 olaparib 1 niraparib 1 montelukast 1 fluorodopa F 18 1 eribulin 1 entrectinib 1 entacapone 1 cobimetinib 1 atezolizumab 1 alectinib 1 Vinorelbine 1 Vincristine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07048249 2026-03-18

Single Arm Romiplostim to Prevent CIT

Children's Hospital Medical Center, Cincinnati

Phase EARLY_PHASE1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡